KLK5 is Associated with the Radioresistance, Aggression, and Progression of Cervical Cancer

Shunqing Zhou,Shuyan Liu,Geng Tian,Lin Zhao,Haichen Wang,Ying Li,Yannan Shen,Liying Han
DOI: https://doi.org/10.1016/j.ygyno.2022.05.010
IF: 5.304
2022-01-01
Gynecologic Oncology
Abstract:Objective. The role of kallikrein-related peptidase 5 (KLK5) has been studied in several diseases, including skin and ovarian cancers. However, its role in cervical cancer remains unclear, particularly in regulating the radiation resistance and growth of cervical cancer cells. Radiation resistance of cervical cancer is associated with local re-currence, distant metastasis, and reduced survival.Methods. We first analyzed radiotherapy-naive samples and relevant clinical data from patients with cervical cancer who received radiotherapy without surgery or other antitumor treatment from 2014 to 2016. Subse-quently, biopsied tissues, in vitro cells, and transplanted tumors in nude mice were investigated.Results. Gene sequencing and clinical data analysis showed that KLK5 overexpression was associated with a poor prognosis post-radiotherapy. In in vitro cell and tumor transplantation experiments, KLK5 overexpression significantly increased radiation resistance. However, downregulating KLK5 expression increased radiosensitiv-ity.Conclusion. Our results confirm that KLK5 is vital to the radioresistance of cervical cancer, and provide a new target and marker for the treatment of radioresistance in cervical cancer.
What problem does this paper attempt to address?